Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma - 10/08/17
, Z.-H. Lin a, 1, J. Chen c, 1, J.-X. Lin a, X. Li a, J.-R. Jiang a, X.-K. Ma a, D.-H. Wu a, Z.-H. Chen a, M. Dong a, L. Wei a, T.-T. Wang a, D.-Y. Ruan a, Z.-X. Lin a, J.-Y. Wen a, X.-Y. Wu a, M.-S. Huang b, ⁎ Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
| páginas | 5 |
| Iconografías | 3 |
| Vídeos | 0 |
| Otros | 0 |
Abstract |
Background |
This study aimed to assess the prognostic value of the serum albumin to globulin ratio (AGR) in cholangiocarcinoma patients after surgery.
Methods |
We retrospectively enrolled 123 cholangiocarcinoma patients who underwent surgical treatment between June 2003 and September2014 at the Third Affiliated Hospital of Sun Yat-sen University. Univariate and multivariate analyses using the Cox regression model were performed to determine the prognostic value of AGR.
Results |
Univariate analysis suggested that AGR was a predictive factor for (overall survival) OS but not for recurrence free survival (RFS). After adjustment for other risk factors, multivariate analysis showed that AGR remained independently associated with OS. The optimal cut-off point for AGR was determined to be 1.44. Kaplan–Meier curves showed that there was a significantly lower mean survival time in the low AGR group compared to the high AGR group. A low AGR was found to be significantly associated with high alkaline phosphatase, gamma-glutamyl transpeptidase, total bilirubin levels and an advanced American Joint Committee on Cancer TNM stage, but a low hemoglobin level.
Conclusion |
In summary, patients with higher AGRs have better outcomes than those with lower AGRs. Preoperative AGR can be a reliable marker for evaluating the prognosis of cholangiocarcinoma patients.
El texto completo de este artículo está disponible en PDF.Keywords : Albumin to globulin ratio, Cholangiocarcinoma, Prognosis, Overall survival, Recurrence free survival
Esquema
Vol 65 - N° 2
P. 83-87 - avril 2017 Regresar al número
Artículo precedente
- Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes
- S. Bonnet, R. Duléry, K. Regany, M. Bouketouche, L. Magro, V. Coiteux, S. Alfandari, C. Berthon, B. Quesnel, I. Yakoub-Agha
- Low serum selenium concentrations in French patients with measles
- M. Garcia, A. Pineau, O. Guillard, S. Ragot, N. Lévêque, G. Agius
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?